220 related articles for article (PubMed ID: 33823077)
21. The Impact of Human Papillomavirus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) on Nutritional Outcomes.
Harrowfield J; Isenring E; Kiss N; Laing E; Lipson-Smith R; Britton B
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33557340
[TBL] [Abstract][Full Text] [Related]
22. CE: Human Papillomavirus-Related Oropharyngeal Cancer: A Review of Nursing Considerations.
McKiernan J; Thom B
Am J Nurs; 2016 Aug; 116(8):34-43. PubMed ID: 27428508
[TBL] [Abstract][Full Text] [Related]
23. HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches.
Tornesello ML; Perri F; Buonaguro L; Ionna F; Buonaguro FM; Caponigro F
Cancer Lett; 2014 Sep; 351(2):198-205. PubMed ID: 24971935
[TBL] [Abstract][Full Text] [Related]
24. Rate of locoregional recurrence among patients with oropharyngeal squamous cell carcinoma with known HPV status: a systematic review.
Asheer J; Jensen JS; Grønhøj C; Jakobsen KK; Buchwald CV
Acta Oncol; 2020 Sep; 59(9):1131-1136. PubMed ID: 32406799
[No Abstract] [Full Text] [Related]
25. Post-therapeutic surveillance of HPV-driven oropharyngeal cancers: are we ready to change our practices?
Mirghani H; Troux C; Leroy C; El Bedoui S; Aupérin A; Garic F; Bozec A; Schiappa R; Blanchard P; Gorphe P; Culié D
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3811-3820. PubMed ID: 37010600
[TBL] [Abstract][Full Text] [Related]
26. Cohort profile: indigenous human papillomavirus and oropharyngeal squamous cell carcinoma study - a prospective longitudinal cohort.
Jamieson LM; Garvey G; Hedges J; Leane C; Hill I; Brown A; Ju X; Sethi S; Roder D; Logan RM; Johnson N; Smith M; Antonsson A; Canfell K
BMJ Open; 2021 Jun; 11(6):e046928. PubMed ID: 34083343
[TBL] [Abstract][Full Text] [Related]
27. Knowledge of Human Papillomavirus (HPV) and Oropharyngeal Cancer and Acceptability of the HPV Vaccine among Dental Students.
Farsi NJ; Al Sharif S; Al Qathmi M; Merdad M; Marzouki H; Merdad L
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3595-3603. PubMed ID: 33369457
[TBL] [Abstract][Full Text] [Related]
28. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
[TBL] [Abstract][Full Text] [Related]
29. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
[TBL] [Abstract][Full Text] [Related]
30. Clinical features and treatment strategy for HPV-related oropharyngeal cancer.
Okami K
Int J Clin Oncol; 2016 Oct; 21(5):827-835. PubMed ID: 27380170
[TBL] [Abstract][Full Text] [Related]
31. [Knowledge of Dutch dentists regarding HPV associated cancer of the oropharynx].
Poelman MR; Brand HS; de Visscher JGAM; Jager DHJ
Ned Tijdschr Tandheelkd; 2021 Nov; 128(11):557-563. PubMed ID: 34747166
[TBL] [Abstract][Full Text] [Related]
32. Sexual Health and Interpersonal Relationships After Chemoradiation Therapy for Human Papillomavirus-Associated Oropharyngeal Cancer: A Cross-sectional Study.
Casswell G; Gough K; Drosdowsky A; Bressel M; Coleman A; Shrestha S; D'Costa I; Fua T; Tiong A; Liu C; Rischin D; McDowell L
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):382-393. PubMed ID: 33171200
[TBL] [Abstract][Full Text] [Related]
33. Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified Chemoradiotherapy.
Pearlstein KA; Wang K; Amdur RJ; Shen CJ; Dagan R; Weiss J; Grilley-Olson JE; Zanation A; Hackman TG; Thorp BD; Blumberg JM; Patel S; Sheets N; Weissler MC; Mendenhall WM; Chera BS
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):646-653. PubMed ID: 30395903
[TBL] [Abstract][Full Text] [Related]
34. Worldwide trend in human papillomavirus-attributable cancer incidence rates between 1990 and 2012 and Bayesian projection to 2030.
Wu J; Xiao F; Zheng Y; Lin Y; Wang HL
Cancer; 2021 Sep; 127(17):3172-3182. PubMed ID: 33974715
[TBL] [Abstract][Full Text] [Related]
35. Factors associated with the quality of life for hospitalized patients with HPV-associated oropharyngeal squamous cell carcinoma.
Yin X; Shan C; Wang J; Zhang H
Oral Oncol; 2020 Apr; 103():104590. PubMed ID: 32050152
[TBL] [Abstract][Full Text] [Related]
36. Development and Validation of a Decision Analytical Model for Posttreatment Surveillance for Patients With Oropharyngeal Carcinoma.
Nair V; Auger S; Kochanny S; Howard FM; Ginat D; Pasternak-Wise O; Juloori A; Koshy M; Izumchenko E; Agrawal N; Rosenberg A; Vokes EE; Skandari MR; Pearson AT
JAMA Netw Open; 2022 Apr; 5(4):e227240. PubMed ID: 35416988
[TBL] [Abstract][Full Text] [Related]
37. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
[TBL] [Abstract][Full Text] [Related]
38. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus in oropharyngeal cancer: The changing face of a disease.
Mallen-St Clair J; Alani M; Wang MB; Srivatsan ES
Biochim Biophys Acta; 2016 Dec; 1866(2):141-150. PubMed ID: 27487173
[TBL] [Abstract][Full Text] [Related]
40. Oropharyngeal squamous cell carcinoma and human papillomavirus-associated cancers in women: epidemiologic evaluation of association.
Biron VL; Côté DW; Seikaly H
J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S65-9. PubMed ID: 21453664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
